Tzu-Ping Lin
Dr. Lin Tzu-Ping is a distinguished urologist and researcher with extensive contributions to the fields of urological oncology, prostate cancer, and upper urinary tract urothelial carcinoma. His prolific publication record spans over two decades, encompassing peer-reviewed articles in high-impact journals, such as The Lancet Oncology, Scientific Reports, and Cancer Research. Dr. Lin has significantly advanced the understanding of neuroendocrine differentiation in prostate cancer, the clinical utility of prostate health indices, and the role of autophagy in cancer cell survival. His collaborative work includes multinational studies, population-based analyses, and innovations in diagnostic imaging and surgical techniques. As a scientific counselor, Dr. Lin's expertise offers valuable insights into translational research, clinical trial design, and the development of novel therapeutics for urological malignancies.
14th August 2025
| Time | Session |
|---|---|
|
13:30
15:00
|
Free Paper 【Podium】 (1)
Oncology Prostate (A)
TICC - 1F 102
|
17th August 2025
| Time | Session |
|---|---|
|
12:00
13:00
|
Breaking new ground: PARPi + ARPi combination therapy in mCRPC
TICC - 2F 201AF
|
|
13:30
15:00
|
TICC - 2F 201BC
|